Biotechnology and gene-editing are seen as a way to deliver high-yield stability to the wheat business. U.S. Wheat Associates Director of Trade Policy Peter Laudeman said this technology is on the horizon. “You’ve got this company out of Argentina, Bioceres that’s bringing GMO HB4 wheat to the market,” said Laudeman. “They’ve already commercialized in Argentina but would like to bring that to the U.S. and Australia. They’re going through the U.S. regulatory process right now. ” The U.S. wheat industry supports the commercialization of biotech wheat as long as it is done the right way and doesn’t upset export markets. Listen to the full interview.
News Categories
Latest RRFN Podcasts
Subscribe to RRFN
Get a weekly digest from RRFN to stay up-to-date on all the latest news in agriculture.